{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:11:48Z","timestamp":1793333508849,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s41181-019-0071-6","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T13:03:03Z","timestamp":1565010183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Improved synthesis of [18F] fallypride and characterization of a Huntington\u2019s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2\/D3 receptors"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7905-1043","authenticated-orcid":false,"given":"Tuulia","family":"Huhtala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Poutiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Rytk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teija","family":"Parkkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iiris","family":"Kasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu J.","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teija","family":"Koivula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kontkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wityak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Dominiquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"71_CR1","first-page":"815","volume":"44","author":"DL Alexoff","year":"2003","unstructured":"Alexoff DL, Vaska P, Marsteller D, Gerasimov T, Li J, Logan J, et al. Reproducibility of [11C] raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med. 2003;44:815\u201322.","journal-title":"J Nucl Med"},{"key":"71_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1242\/dmm.002451","volume":"2","author":"DE Ehrnhoefer","year":"2009","unstructured":"Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR. Mouse models of Huntington disease: variations on a theme. Dis Model Mech. 2009;2:123\u20139.","journal-title":"Dis Model Mech"},{"key":"71_CR3","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2174\/092986706777935258","volume":"13","author":"PH Elsinga","year":"2006","unstructured":"Elsinga PH, Hatano K, Ishiwata K. PET tracers for imaging of the dopaminergic system. Curr Med Chem. 2006;13:2139\u201353.","journal-title":"Curr Med Chem"},{"issue":"Pt 3","key":"71_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/brain\/120.3.503","volume":"120","author":"N Ginovart","year":"1997","unstructured":"Ginovart N, Lundin A, Farde L, Halldin C, B\u00e4ckman L, Swahn CG, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease. Brain. 1997;120(Pt 3):503\u201314.","journal-title":"Brain."},{"key":"71_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2967\/jnumed.116.180497","volume":"58","author":"J H\u00e4ggkvist","year":"2017","unstructured":"H\u00e4ggkvist J, T\u00f3th M, Tari L, Varn\u00e4s K, Svedberg M, Forsberg A, et al. Longitudinal small-animal PET imaging of the zQ175 mouse model of Huntington disease shows in vivo changes of molecular targets in the striatum and cerebral cortex. J Nucl Med. 2017;58:617\u201322.","journal-title":"J Nucl Med"},{"key":"71_CR6","unstructured":"Heikkinen T, Bragge T, Lehtim\u00e4ki K, Parkkari T, Puoliv\u00e4li J, Howland D, et al. Characterization of behavioral changes, MRI brain Volumetry and MR spectroscopy in zQ175 Knock-in Delta neo minus mouse model of Huntington\u2019s disease: Malta; 2017."},{"key":"71_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtim\u00e4ki K, Vartiainen N, Puoliv\u00e4li J, Hendricks SJ, Glaser JR, et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS One. 2012;7:e50717.","journal-title":"PLoS One"},{"key":"71_CR8","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1039\/C3CC47616B","volume":"50","author":"MR Javed","year":"2014","unstructured":"Javed MR, Chen S, Lei J, Collins J, Sergeev M, Kim H-K, et al. High yield and high specific activity synthesis of [18F] fallypride in a batch microfluidic reactor for micro-PET imaging. Chem Commun (Camb). 2014;50:1192\u20134.","journal-title":"Chem Commun (Camb)"},{"key":"71_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153\u20138.","journal-title":"Neuroimage."},{"key":"71_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Strobel SA, Draths KM, Wales JL, Dervan P. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group. Cell. 1993;72:971\u201383.","journal-title":"Cell."},{"key":"71_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS One. 2012;7:e49838.","journal-title":"PLoS One"},{"key":"71_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0969-8051(94)00117-3","volume":"22","author":"J Mukherjee","year":"1995","unstructured":"Mukherjee J, Yang ZY, Das MK, Brown T. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl Med Biol. 1995;22:283\u201396.","journal-title":"Nucl Med Biol"},{"key":"71_CR13","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00415-014-7302-2","volume":"261","author":"F Niccolini","year":"2014","unstructured":"Niccolini F, Su P, Politis M. Dopamine receptor mapping with PET imaging in Parkinson\u2019s disease. J Neurol. 2014;261:2251\u201363.","journal-title":"J Neurol"},{"key":"71_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.14336\/AD.2015.0330","volume":"6","author":"C Rangel-Barajas","year":"2015","unstructured":"Rangel-Barajas C, Coronel I, Flor\u00e1n B. Dopamine receptors and neurodegeneration. Aging Dis. 2015;6:349\u201368.","journal-title":"Aging Dis"},{"key":"71_CR15","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2967\/jnumed.110.078451","volume":"51","author":"A Rominger","year":"2010","unstructured":"Rominger A, Mille E, Zhang S, B\u00f6ning G, F\u00f6rster S, Nowak S, et al. Validation of the octamouse for simultaneous [18F] fallypride small-animal PET recordings from 8 mice. J Nucl Med. 2010;51:1576\u201383.","journal-title":"J Nucl Med"},{"key":"71_CR16","first-page":"964","volume":"46","author":"T Siessmeier","year":"2005","unstructured":"Siessmeier T, Zhou Y, Buchholz H-G, Landvogt C, Vernaleken I, Piel M, et al. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med. 2005;46:964\u201372.","journal-title":"J Nucl Med"},{"key":"71_CR17","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","volume":"23","author":"GA Smith","year":"2014","unstructured":"Smith GA, Rocha EM, McLean JR, Hayes MA, Izen SC, Isacson O, et al. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease. Hum Mol Genet. 2014;23:4510\u201327.","journal-title":"Hum Mol Genet"},{"key":"71_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5498\/wjp.v3.i3.62","volume":"3","author":"JJ Vattakatuchery","year":"2013","unstructured":"Vattakatuchery JJ, Kurien R. Acetylcholinesterase inhibitors in cognitive impairment in Huntington\u2019s disease: a brief review. World J Psychiatry. 2013;3:62\u20134.","journal-title":"World J Psychiatry"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-019-0071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41181-019-0071-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-019-0071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:05:39Z","timestamp":1596495939000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-019-0071-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1186\/s41181-019-0071-6","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"6 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give their consent for publish this submitted article and figures attached to it.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}